You have 9 free searches left this month | for more free features.

City

Beijing (2)

Ann Arbor (1)

Orsay (1)

Condition

Prostate Cancer (2)

Hepatocellular Carcinoma (1)

Lymphangioleiomyomatosis (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

early phase 1 (1)

n/a (1)

phase 2 (1)

Sponsor

Commissariat A L'energie Atomique (1)

Peking Union Medical College Hospital (1)

Peking University Cancer Hospital & Institute (1)

University of Michigan (1)

Collaborator

Assistance Publique - Hopitaux de Paris (1)

National Cancer Institute (NCI) (1)

National Institutes of Health (NIH) (1)

Intervention

11c-choline (4)

11c-sarcosine (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (4)

Study Type

Interventional (3)

Observational (1)

11c-choline

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

Not yet recruiting

Lymphangioleiomyomatosis

11C-Choline

Beijing, Dongcheng, China

Peking union medical college hospital

Oct 8, 2021

Prostate Cancer Trial in Beijing (11C-Choline)

Recruiting

Prostate Cancer

11C-Choline

Beijing, Beijing, China

Beijing Cancer Hospital

Dec 11, 2021

Carbon-11 Labeled Sarcosine in Prostate Cancer

Completed

Prostate Cancer

11C-sarcosine
11C-choline

Ann Arbor, Michigan

University of Michigan Health Systems

Nov 7, 2017

Hepatocellular Carcinoma Trial in Orsay (11C-Choline)

Unknown status

Hepatocellular Carcinoma

11C-Choline

Orsay, France

CEA-SHFJ

Jun 20, 2011